We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
LPL Financial
LPLA
$29.5B
| $15M | 0.03% |
84,359
+1,317
| +2% | +$250K |
|
577
TE Connectivity
TEL
$63.5B
| $14.9M | 0.03% |
135,069
-43,644
| -24% | -$5.41M |
|
578
Vornado Realty Trust
VNO
$7.23B
| $14.7M | 0.03% |
522,873
+378,370
| +262% | +$13.5M |
|
|
VMW
579
DELISTED
VMware, Inc
VMW
| $14.6M | 0.03% |
128,571
-614,261
| -83% | -$69.7M |
|
580
W.R. Berkley
WRB
$26.1B
| $14.5M | 0.03% |
325,379
-242,293
| -43% | -$11M |
|
581
Welltower
WELL
$165B
| $14.5M | 0.03% |
176,122
+4,239
| +2% | +$377K |
|
582
Urban Outfitters
URBN
$6.74B
| $14.5M | 0.03% |
776,900
-328,183
| -30% | -$7.44M |
|
583
RingCentral
RNG
$5.34B
| $14.5M | 0.03% |
279,135
+276,047
| +8,939% | +$20.9M |
|
584
Virtu Financial
VIRT
$4.92B
| $14.4M | 0.03% |
615,073
-540,609
| -47% | -$15.5M |
|
585
Hain Celestial
HAIN
$51.8M
| $14.3M | 0.03% |
609,673
+454,507
| +293% | +$12.9M |
|
586
Integra LifeSciences
IART
$1.36B
| $14.3M | 0.03% |
263,943
+135,062
| +105% | +$8.11M |
|
587
Targa Resources
TRGP
$57.2B
| $14.2M | 0.03% |
238,016
-76,756
| -24% | -$5.51M |
|
588
Capri Holdings
CPRI
$1.77B
| $14.2M | 0.03% |
352,454
+191,862
| +119% | +$8.93M |
|
|
CMA
589
DELISTED
Comerica
CMA
| $14.1M | 0.03% |
194,874
-154,843
| -44% | -$12.5M |
|
590
Timken Company
TKR
$8.9B
| $14M | 0.03% |
268,504
+94,501
| +54% | +$5.52M |
|
591
OneMain Financial
OMF
$7.34B
| $13.9M | 0.03% |
375,245
+30,051
| +9% | +$1.3M |
|
592
Bio-Techne
TECH
$11.2B
| $13.8M | 0.03% |
162,088
-9,280
| -5% | -$870K |
|
593
Credicorp
BAP
$30.3B
| $13.8M | 0.03% |
115,036
+673
| +0.6% | +$92.5K |
|
594
KE Holdings
BEKE
$18.8B
| $13.7M | 0.03% |
764,050
-41,329
| -5% | -$582K |
|
595
Enovis
ENOV
$1.44B
| $13.5M | 0.03% |
246,127
+205,732
| +509% | +$13.3M |
|
596
Regal Rexnord
RRX
$11.6B
| $13.5M | 0.03% |
119,319
-84,710
| -42% | -$10.8M |
|
597
Deere & Co
DE
$166B
| $13.4M | 0.03% |
45,590
-75,221
| -62% | -$27.7M |
|
598
Dycom Industries
DY
$12.2B
| $13.4M | 0.03% |
150,352
+37,406
| +33% | +$3.33M |
|
599
Minerals Technologies
MTX
$2.32B
| $13.4M | 0.03% |
221,857
+8,271
| +4% | +$528K |
|
600
Xerox
XRX
$423M
| $13.4M | 0.03% |
909,031
+144,502
| +19% | +$2.56M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.